Clinical Trials Browser

Has results × Bites and Stings × blinatumomab × Clear all

NCT00274742 2015-01-16

Safety Study of the Bispecific T-cell Engager Blinatumomab (MT103) in Patients With Relapsed NHL

Phase 1 Completed

76 enrolled 15 charts

Bites and Stings, Lymphoma, Non-Hodgkin, Recurrence